Invention Grant
- Patent Title: TEC family kinase inhibitor adjuvant therapy
-
Application No.: US14070420Application Date: 2013-11-01
-
Publication No.: US09717731B2Publication Date: 2017-08-01
- Inventor: Joseph J. Buggy , Tarak D. Mody , John C. Byrd , Betty Y. Chang , Jason A. Dubovsky , Natarajan Muthusamy , Amy Jo Johnson
- Applicant: Pharmacyclics LLC
- Applicant Address: US CA Sunnyvale
- Assignee: Pharmacyclics LLC
- Current Assignee: Pharmacyclics LLC
- Current Assignee Address: US CA Sunnyvale
- Agency: Foley Hoag LLP
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61N5/10 ; A61K45/06
Abstract:
Described herein are methods and compositions comprising a covalent TEC family kinase inhibitor for use in adjuvant therapy, including adjuvant cancer therapy, vaccination and treatment of immune disorders and pathogenic infections.
Public/Granted literature
- US20140134265A1 TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY Public/Granted day:2014-05-15
Information query
IPC分类:
